We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Study Details

Healthy Adults, Age 18-65

Study Number

8446-278 B3a

Group

Part B Cohort 3a

Gender

both

Age

18-65

Location

Daytona Beach, Florida

Compensation

$6,463

Study Dates

Jun. 22 - Jul. 21, 2021

Additional Information

The investigational drug in this research study is being developed for the potential treatment of nonalcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease. This is the first time that this study drug is being given to humans.

The purpose of Part B is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it. You will receive an oral dose of the study drug or placebo in the form of capsules once daily on Days 1 to 15. You will also receive a single oral dose of midazolam in the form of a liquid on Check-in Day and on Day 15. Midazolam is a short acting sedative used prior to invasive diagnostic or surgical procedures.

• Healthy Adults, Age 18-65

• Women must be surgically sterile or postmenopausal

• BMI (body mass index) 18.5-40

• Available for 1 stay of 22 overnights & 1 follow up visit

• Compensation up to $6,463 may be provided for time and participation.

Details

Call Now to Schedule Your Screening Appointment! 

Check-in: Jun 22
Check-out: Jull 14

Follow up Visit: Jul 21

 

Study Number

8446-278 B3a

Group

Part B Cohort 3a

Gender

both

Age

18-65

Location

Daytona Beach, Florida

Compensation

$6,463

Study Dates

Jun. 22 - Jul. 21, 2021

Additional Information

The investigational drug in this research study is being developed for the potential treatment of nonalcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease. This is the first time that this study drug is being given to humans.

The purpose of Part B is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it. You will receive an oral dose of the study drug or placebo in the form of capsules once daily on Days 1 to 15. You will also receive a single oral dose of midazolam in the form of a liquid on Check-in Day and on Day 15. Midazolam is a short acting sedative used prior to invasive diagnostic or surgical procedures.

• Healthy Adults, Age 18-65

• Women must be surgically sterile or postmenopausal

• BMI (body mass index) 18.5-40

• Available for 1 stay of 22 overnights & 1 follow up visit

• Compensation up to $6,463 may be provided for time and participation.

Details

Call Now to Schedule Your Screening Appointment! 

Check-in: Jun 22
Check-out: Jull 14

Follow up Visit: Jul 21

 

Calculate Your BMI!

Calculate Your BMI!